Plexera Signs Early-Access Customer for ProteomicProcessor | GenomeWeb

NEW YORK (GenomeWeb News) - Plexera said today it has inked an agreement with an undisclosed early-access customer for its antibody discovery system, which it expects to launch in May 2008. 
 
Plexera said the partner, a therapeutic antibody company, intends to purchase one of the ProteomicProcessor Systems when the platform is commercially available.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.